The Feasibility of an Experimental Hypobaric Simulation to Evaluate the Safety of Closed-Loop Insulin Delivery Systems in Flight-Related Atmospheric Pressure Changes
Diabetes Technology & Therapeutics · 2025
DOI: 10.1089/dia.2024.0380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Ka Siu Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, University of Surrey, Guildford, United Kingdom. Hauptthemen laut MEDLINE: Insulin Infusion Systems, Diabetes Mellitus, Type 1, Insulin, Atmospheric Pressure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Hybrid closed-loop (HCL) systems remain underexplored within aviation, and as atmospheric pressure changes can independently affect insulin pumps and continuous glucose monitoring readings, this preliminary study assessed the feasibility of HCL safety evaluation, in both fasting and post-prandial states, by using hypobaric chamber to simulate flights. Participants with type 1 diabetes and on HCL were studied: Medtronic Guardian 4-Medtronic 780G-SmartGuard (n = 4), Dexcom G6-Omnipod DASH-Android APS (n = 1), and Dexcom G6-Ypsomed Pump-CamAPS (n = 1). Flight cabin pressures of 550 mmHg and 750 mmHg were simulated in a hypobaric chamber. Seven-hundred-50 glucose measurements were taken, with glucose levels demonstrating a stable decline to 4 mmol/L during fasting. To maintain a tight fasting and post-prandial glucose range across the different pressure settings, the HCL administered insulin as expected. While not demonstrating any apparent issues, repeating flight simulation protocol with other systems, examining longer flights, and undertaking larger, powered randomised controlled trials can confirm their safety in aviation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences, University of Surrey, Guildford, United Kingdom.
- CEDAR Centre, Royal Surrey County Hospital, Guildford, United Kingdom.
- Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
- QinetiQ, Farnborough, United Kingdom.
- Department of Endocrinology, KU, Leuven, Belgium.
- Civil Aviation Authority, Crawley, United Kingdom.
ORCID-Profile: Ka Siu Fan, Petra M Baumann, Julia K Mader
Zitieren
APA
Fan, K. S., Shojaee-Moradie, F., Manoli, A., Baumann, P. M., Koehler, G., Edwards, V., Lee, V., Mathieu, C., Mader, J. K., Russell-Jones, D., & EASA Diabetes Consortium (2025). The Feasibility of an Experimental Hypobaric Simulation to Evaluate the Safety of Closed-Loop Insulin Delivery Systems in Flight-Related Atmospheric Pressure Changes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0380
Vancouver
Fan KS, Shojaee-Moradie F, Manoli A, Baumann PM, Koehler G, Edwards V, et al. The Feasibility of an Experimental Hypobaric Simulation to Evaluate the Safety of Closed-Loop Insulin Delivery Systems in Flight-Related Atmospheric Pressure Changes. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2024.0380
BibTeX
@article{Fan2025,
author = {Fan, Ka Siu and Shojaee-Moradie, Fariba and Manoli, Antonios and Baumann, Petra M and Koehler, Gerd and Edwards, Victoria and Lee, Vivienne and Mathieu, Chantal and Mader, Julia K and Russell-Jones, David and EASA Diabetes Consortium, EASA Diabetes Consortium},
title = {The Feasibility of an Experimental Hypobaric Simulation to Evaluate the Safety of Closed-Loop Insulin Delivery Systems in Flight-Related Atmospheric Pressure Changes},
journal = {Diabetes Technology & Therapeutics},
year = {2025},
doi = {10.1089/dia.2024.0380}
}
EUVIMED